Get the Stockscreener App
10.53
0.00%
0.00
After Hours:
10.53
Drugs Made In America Acquisition Corp stock is traded at $10.53, with a volume of 328.10K.
It is up +0.00% in the last 24 hours and up +0.10% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.53
Open:
$10.53
24h Volume:
328.10K
Relative Volume:
2.42
Market Cap:
$355.04M
Revenue:
-
Net Income/Loss:
$5.94M
P/E Ratio:
59.42
EPS:
0.1772
Net Cash Flow:
$-539.20K
1W Performance:
+0.14%
1M Performance:
+0.10%
6M Performance:
+2.33%
1Y Performance:
+4.99%
1-Day Range:
$10.53
$10.54
1-Week Range:
$10.53
$10.55
52-Week Range:
$10.03
$10.55
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
646-726-7074
Address
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs LION, XXI, UMAC, DMII, BCSS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.53 | 355.04M | 0 | 5.94M | -539.20K | 0.1772 |
LION
Lionsgate Studios Corp
|
12.45 | 3.61B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
7.92 | 2.78B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
15.44 | 673.32M | 11.20M | -19.19M | -23.24M | -0.7527 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.01 | 637.32M | 0 | 4.19M | 0 | 0.065 |
BCSS
Bain Capital Gss Investment Corp
|
10.18 | 593.93M | 0 | 0 | 0 | 0.0729 |
Drugs Made In America Acquisition Corp Stock (DMAA) Latest News
Vote math updated for Drugs Made In America (DMAA) in proxy amendment - Stock Titan
Drugs Made In America Acquisition II Corp. 10-K Annual Report: Business Strategy, Acquisition Focus, and Management Overview - Minichart
Drugs Made In America Acquisition Corp. (DMAA): SPAC Focusing on AI, Machine Learning, and Pharmaceutical Acquisition Opportunities - Minichart
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Drugs Made In America (NASDAQ: DMAA) details SPAC cash, LOI and risks - Stock Titan
Drugs Made In America Acquisition II Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Drugs Made In America Acquisition II (DMII) logs $4.2M income, flags going-concern risk - Stock Titan
Paloma Acquisition Corp I: Performance & Quotes, PALO Stock Price on Nasdaq Exchange - marketscreener.com
Drugs Made in America (DMAA) asks investors to extend SPAC deal deadline - Stock Titan
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Sees Large Decrease in Short Interest - MarketBeat
Chipmakers Recap: Can Drugs Made In America Acquisition Corp Equity Right sustain earnings growth2026 Performance Recap & Daily Entry Point Trade Alerts - baoquankhu1.vn
Weekly Recap: Is Drugs Made In America Acquisition Corp a momentum stock2026 Stock Rankings & High Conviction Trade Alerts - baoquankhu1.vn
JPMorgan Chase & Co. Buys Shares of 99,690 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Aug Chart Watch: What makes Drugs Made In America Acquisition Corp stock attractive today2026 Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%What's Next? - MarketBeat
Targets Report: Can Drugs Made In America Acquisition Corp Equity Right deliver alphaStop Loss & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Drugs Made In America Acquisition Corp.Rights (NQ: DMAAR - The Chronicle-Journal
Power Analytics Global Corp signed a letter of intent to acquire Drugs Made In America Acquisition Corp. in a reverse merger transaction for $1.0 billion. - marketscreener.com
Drugs Made In America Acquisition Corp. Signs LOI for De-SPAC Merger with Power Analytics Global Corp - Minichart
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Competitors - Meyka
Drugs Made in America SPAC Signs Power Analytics LOI - TipRanks
Drugs Made in America Acquisition Corp. signs LOI for de-SPAC with Power Analytics - Investing.com
Drugs Made In America Acquisition CorpEnters Loi For De-Spac With Power Analytics Global CorpSEC Filing - TradingView
Drugs Made in America to pursue de-SPAC with Power Analytics Global at ~$1.0B valuation - TradingView — Track All Markets
De-SPAC LOI values Power Analytics at $1.0B with DMAA (NASDAQ: DMAA) - Stock Titan
Idea Acquisition Corp.: Performance & Quotes, IACO Stock Price on Nasdaq Exchange - marketscreener.com
Willow Lane Acquisition Corp. II: Performance & Quotes, WLII Stock Price on Nasdaq Exchange - marketscreener.com
Why Is Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Stock Up Today? - Meyka
Death Cross: Can Drugs Made In America Acquisition Corp Equity Right sustain earnings growth2026 Sector Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Chart Watch: Is Drugs Made In America Acquisition Corp Equity Right stock influenced by commodity pricesEarnings Overview Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Drugs Made In America Acquisition II Corp. Announces $1.4 Million Convertible Notes Financing Agreement with Alpha Multi Family Office - Minichart
Drugs Made In America Acquisition II Corp. enters $300,000 convertible note agreement - Investing.com Australia
Drugs Made In America Acquisition II Corp. enters $300,000 convertible note agreement By Investing.com - Investing.com South Africa
Drugs Made In America II Issues Interim Convertible Note - TipRanks
Drugs Made In America Acquisition II Finalizes $1.4M Notes Deal, Adds $300K Interim Convertible - TradingView
$300K zero‑interest note backs Drugs Made In America II (NASDAQ: DMII) - Stock Titan
Drugs Made in America Acquisition II Delays Annual Filing - TipRanks
Drugs Made in America Delays Annual Filing - TipRanks
Late 10-K notice — Drugs Made in America (NASDAQ: DMAA) delays FY2025 filing - Stock Titan
DMII (NASDAQ: DMII) files 12b-25—expects to file 10-K by Apr 15, 2026 - Stock Titan
Drugs Made In America Acquisition II Corp.Right (Nasdaq:DMIIR) Stock Quote - The Chronicle-Journal
FitLife Brands, Inc. 2025 Financial Performance: Online & Wholesale Revenue, Margins, and Strategic Initiatives - Minichart
Cambridge Acquisition Corp.: Performance & Quotes, CAQ Stock Price on Nasdaq Exchange - MarketScreener
Sentiment Review: Can WBPRBC stock double in the next year2026 Investor Takeaways & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
DMAAR Stock Price, News & Analysis - Stock Titan
Market Rankings: Is Drugs Made In America Acquisition Corp Equity Rights growth already priced in2026 Fundamental Recap & Reliable Breakout Forecasts - baoquankhu1.vn
Entry Recap: Is Drugs Made In America Acquisition Corp affected by consumer sentimentTrade Volume Summary & Smart Swing Trading Alerts - baoquankhu1.vn
Drugs Made In America Acquisition Corp. issues $100,000 convertible note as part of $500,000 financing - Investing.com Australia
Drugs Made in America (DMAA) seeks shareholder vote to extend SPAC deadline - Stock Titan
Drugs Made In America Signs Financing and Sponsor Deal - TipRanks
Drugs Made In America Acquisition Secures $500,000 Financing; Issues $100,000 Interim Note - TradingView
Drugs Made In America Acquisition Corp Stock (DMAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):